Alteration of circulating miRNAs during myocardial infarction and association with lipid levels
Laboratory Medicine · 02.05.2024 · 55 (3) · 361-372
DOI: 10.1093/labmed/lmad094 ↗Kurz gefasst
Fachartikel in der Zeitschrift Laboratory Medicine, online erschienen am 04.12.2023. Verfasst von Aybike Sena Ozuynuk-Ertugrul und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey. Hauptthemen laut MEDLINE: Myocardial Infarction, Circulating MicroRNA. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scientific Research Projects Coordination Unit of Istanbul University.
Abstract (Originalsprache)
Background
Increasing mortality and morbidity of coronary artery disease (CAD) highlight the emerging need for novel noninvasive markers such as circulating microRNAs (miRNAs).
Objective
To evaluate the circulating levels of miR-126-3p, miR-210-3p, let-7g-5p, and miR-326, and their associations with known contributors to CAD, in CAD subgroups.
Methods
We divided the cohort into 4 groups: non-CAD controls (≤30% stenosis; n = 55), and patients with stable angina pectoris (SAP; n = 48), unstable AP (UAP; n = 46), and myocardial infarction (MI; n = 36). The circulating levels of miR-126-3p, miR-210-3p, let-7g-5p, and miR-326 were determined using TaqMan Advanced miRNA Assays in serum specimens.
Results
Circulating miR-126-3p levels were lower in the MI and UAP groups, compared with the non-CAD group, whereas miR-210-3p circulating levels were lower in the MI group than others. The levels of circulating let-7g-5p were shown to be useful for distinguishing UAP from MI, and there were substantial differences in circulating let-7g-5p levels between the UAP and MI groups. Moreover, lipid levels and ratios were lower in individuals with high circulating miR-126-3p and miR-210-3p levels.
Conclusions
The study results suggest that circulating miR-126-3p, miR-210-3p, and let-7g-5p are differentiated between different clinical presentations of CAD and associated with lipid levels, which are important risk factors and determinants of CAD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Genetics, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey.
- Institute of Graduate Studies in Health Sciences, Istanbul University, Istanbul, Turkey.
- Department of Cardiology, Faculty of Medicine, Ufuk University, Ankara, Turkey.
ORCID-Profile: Neslihan Coban
Förderung
- Scientific Research Projects Coordination Unit of Istanbul University
Zitieren
APA
Ozuynuk-Ertugrul, A. S., Ekici, B., Erkan, A. F., & Coban, N. (2024). Alteration of circulating miRNAs during myocardial infarction and association with lipid levels. Laboratory Medicine, 55(3), 361-372. https://doi.org/10.1093/labmed/lmad094
Vancouver
Ozuynuk-Ertugrul AS, Ekici B, Erkan AF, Coban N. Alteration of circulating miRNAs during myocardial infarction and association with lipid levels. Laboratory Medicine. 2024;55(3):361-372. doi:10.1093/labmed/lmad094
BibTeX
@article{OzuynukErtugrul2024,
author = {Ozuynuk-Ertugrul, Aybike Sena and Ekici, Berkay and Erkan, Aycan Fahri and Coban, Neslihan},
title = {Alteration of circulating miRNAs during myocardial infarction and association with lipid levels},
journal = {Laboratory Medicine},
year = {2024},
volume = {55},
number = {3},
pages = {361--372},
doi = {10.1093/labmed/lmad094}
}
EUVIMED